GABAA receptor modulators as anxioselective anxiolytics
- 1 December 2006
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Therapeutic Strategies
- Vol. 3 (4) , 475-481
- https://doi.org/10.1016/j.ddstr.2006.10.009
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- A Pyridazine Series of α2/α3 Subtype Selective GABAA Agonists for the Treatment of AnxietyJournal of Medicinal Chemistry, 2006
- Imidazo[1,2-a]pyrimidines as Functionally Selective and Orally Bioavailable GABAAα2/α3 Binding Site Agonists for the Treatment of Anxiety DisordersJournal of Medicinal Chemistry, 2005
- The Reinforcing Properties of Alcohol are Mediated by GABAA1 Receptors in the Ventral PallidumNeuropsychopharmacology, 2003
- Pregabalin in Generalized Anxiety Disorder: A Placebo-Controlled TrialAmerican Journal of Psychiatry, 2003
- Anxiolytic Properties of the Selective, Non-peptidergic CRF1 Antagonists, CP154,526 and DMP695 A Comparison to Other Classes of Anxiolytic AgentNeuropsychopharmacology, 2001
- Paroxetine in the Treatment of Generalized Anxiety DisorderThe Journal of Clinical Psychiatry, 2001
- Pharmacology of recombinant γ‐aminobutyric acidA receptors rendered diazepam‐insensitive by point‐mutated α‐subunitsFEBS Letters, 1998
- Comparison of benzodiazepine (BZ) receptor agonists in two rodent activity testsJournal of Psychopharmacology, 1996
- β-carboline-3-carboxylate-t-butyl ester: A selective BZ1 benzoiazepine receptor antagonistLife Sciences, 1984
- Molecular substrates of anxiety: Clues from the heterogeneity of benzodiazepine receptorsLife Sciences, 1982